Aditxt to launch first-in-human clinical trials for psoriasis therapy

S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Aditxt to launch first-in-human clinical trials for psoriasis therapy

To read the full story on Seeking Alpha, click here.

Aditxt (NASDAQ:ADTX)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Aditxt Charts.

Aditxt (NASDAQ:ADTX)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Aditxt Charts.

ADiTx Therapeutics Inc News

Aditxt Signs a Definitive Agreement to Acquire Appili Therapeutics Inc., Developer of a Biodefense Vaccine Funded by the U.S. Department of Defense (DoD)
Tuesday 2 April 2024 (1 month ago) • Business Wire

Evofem Reports $18.2 million of Phexxi Net Product Sales in 2023
Wednesday 27 March 2024 (1 month ago) • PR Newswire (US)

Form 8-K - Current report
Monday 11 March 2024 (2 months ago) • Edgar (US Regulatory)

For Women Using GLP-1 Receptor Agonists who take Oral Birth Control Pills, Hormone-Free Phexxi Contraceptive Gel is a Logical Solution to Help Prevent Unintended Pregnancy
Thursday 7 March 2024 (2 months ago) • PR Newswire (US)

Form 425 - Prospectuses and communications, business combinations
Monday 4 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 4 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 1 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 29 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K/A - Current report: [Amend]
Thursday 22 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 21 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 16 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 15 February 2024 (3 months ago) • Edgar (US Regulatory)

More ADiTx Therapeutics Inc News Articles

Atacama Resources (PK)

NaturalShrimp (QB)

Verb Technology

Mullen Automotive

BlackStar Enterprise (PK)

International Star (PK)

MicroCloud Hologram

Moon Equity (PK)

Globestar Therapeutics (PK)

Virexit Technologies (PK)

FuelCell Energy

Seven Arts Entertainment (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions